Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?

Australian Journal of Hospital Pharmacy

Volumn 30, Issue 2, 2000, Pages 47-53

  Stowasser, Danielle A ^a,b   Staatz, Christine E ^b   Stowasser, Michael ^b   Coombes, Judith A ^a,b   Collins, David M ^c  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002594096     PISSN: 03106810     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr200030247     Document Type: Article

References (27)

1. Duggan C, Bates I, Hough J, Feldman R. An evidence based approach to improving communication between health care sectors and the management of prescribing drugs. Pharmaceutical Journal 1998; 261: R17.
2. Duffin J, Norwood J, Blenkinsopp A. An investigation into medication changes initiated in general practice after patients are discharged from hospital. Pharmaceutical Journal 1998; 261: R18.
3. Sheehan J, Reardon M, Twomey C, Hyland M. The effects of hospital admission on drug prescribing in an elderly population. Ir Med J 1996; 89: 115.
4. Cochrane RA, Mandal AR, Ledger-Scott M, Walker R. Changes in drug treatment after discharge from hospital in geriatric patients. BMJ 1992; 305: 694-6.
5. Bates DW. Frequency, consequences and prevention of adverse drug events. J Qual Clin Pract 1999; 19: 13-17.
6. Clark RB, Graham JD, Williamson JA. Towards system-wide strategies for reducing adverse drug events. J Qual Clin Pract 1999; 19: 37-40.
7. Bero LA, Lipton HL, Bird JA. Characterization of geriatric drug-related hospital readmissions. Medical Care 1991; 29: 989-1003.
8. Doecke CJ. The Australian Medication Safety Working Group: developing a strategy for reducing adverse drug events in the Australian health system [editorial]. J Qual Clin Pract 1999; 19: 5.
9. Stowasser DA, McGuire TM, Petrie GM, Lauchlan RL, Collins DM. Information quality: a major consideration in the development of medication liaison services. Aust J Hosp Pharm 1997; 27: 362-6.
10. Roughead EE, Gilbert AL, Primrose JG, Sansom LN. Coding drug-related admissions in medical records: is it adequate for monitoring the quality of medication use? Aust J Hosp Pharm 1998; 28: 7-12.
11. Hewitt J. Drug-related unplanned readmissions to hospital. Aust J Hosp Pharm 1995; 25: 400-3.
12. Henderson J, Goldacre MJ, Graveney MJ, Simmons HM. Use of medical record linkage to study readmission rates. BMJ 1989; 299: 709-13.
13. Jha AK, Kuperman GJ, Teich JM, Leape L, Shea B, Rittenberg E, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998; 5: 305-14.
14. Dartnell JGA, Anderson RP, Chohan V, Galbraith KJ, Lyon MEH, Nestor PJ, et al. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 1996; 164: 659-62.
15. Health Information Management Systems. Discharges by DRG. Brisbane: Princess Alexandra Hospital; 1995 2 November.
16. National Coding Centre. The official NCC Australian version of ICD-9-CM. 9th ed. Sydney: National Coding Centre; 1995.
17. Easton KL, Parsons BJ, Starr M, Brien JE. The incidence of drug-related problems as a cause of hospital admissions in children. Med J Aust 1998; 169: 356-9.
18. Claris Corporation. FileMaker Pro for Windows. In: 3.0 ed. Santa Clara: Claris Corporaton: 1995.
19. Norusis MJ. SPSS PC+. Base system user's guide. In: 5.0 ed. Chicago: SPSS Inc; 1992.
20. Wilkinson L. Systat/Sygraph 5.2 for the Macintosh. In: 5.2 ed. Evanston, Illinois: Systat Inc; 1992.
21. Frankl SE, Breeling JL, Goldman L. Preventability of emergent hospital readmissions. Am J Med 1991; 90: 667-74.
22. Malpass A, Helps SC, Sexton EJ, Maiale D, Runciman WB. A classification for adverse drug events. J Qual Clin Pract 1999; 19: 23-6.
23. National Centre for Classification in Health. International statistical classification of diseases and related health problems. 10th revision. Australian Modification (ICD-10 AM). Sydney: National Centre for Classification in Health: 1998.
24. Ashlon CM, Wray NP. A conceptual framework for the study of early readmission as an indicator of quality of care. Soc Sci Med 1996; 43: 1533-41.
25. Macklin J. Issues in pharmaceutical drug use in Australia. Canberra: Department of Human Services and Health; 1992.
26. Runciman WB. Incidents and accidents in health care: it's time! [editorial]. J Qual Clin Pract 1999; 19: 1-2.
27. Khan SA. Descriptions of adverse drug events should be standardised [letter]. BMJ 1999; 318: 127.